Close Menu
Home » Genetic Signatures Launches Analyte-Specific Reagents in US; Eyes FDA Approval for MDx Panels

Genetic Signatures Launches Analyte-Specific Reagents in US; Eyes FDA Approval for MDx Panels

Jul 08, 2016
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Australian molecular diagnostics manufacturer Genetic Signatures recently launched a line of analyte-specific reagents in the US and collaborated with the University of California, Los Angeles to evaluate a multiplex panel assay for enteric protozoan infections with an eye toward regulatory approval and the US diagnostics market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Gigantopithecus' Place in the Family

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

One Year On

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

With BGI There

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

Science Papers Describe How Gut Microbiome Transplant Affects Neuron Growth, More

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In PCR

  1. Inflammatix Inks BARDA Contract for up to $72M

  2. 10x Genomics' Fully Automated Single-Cell Library Prep Platform Coming in Early 2020

    Premium

  3. Biocept Q3 Revenues Nearly Double

  4. T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

  5. Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.